Zerumin ACAS# 176050-48-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 176050-48-9 | SDF | Download SDF |
PubChem ID | 11723433 | Appearance | Powder |
Formula | C20H30O3 | M.Wt | 318.5 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (Z)-5-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-formylpent-3-enoic acid | ||
SMILES | CC1(CCCC2(C1CCC(=C)C2CC=C(CC(=O)O)C=O)C)C | ||
Standard InChIKey | ZAWWSYIDZKWRAI-DTFKRFDDSA-N | ||
Standard InChI | InChI=1S/C20H30O3/c1-14-6-9-17-19(2,3)10-5-11-20(17,4)16(14)8-7-15(13-21)12-18(22)23/h7,13,16-17H,1,5-6,8-12H2,2-4H3,(H,22,23)/b15-7-/t16-,17-,20+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Zerumin A inhibits the proliferation and migration steps, to prevent angiogenesis progress. |
Targets | EGFR |
Zerumin A Dilution Calculator
Zerumin A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.1397 mL | 15.6986 mL | 31.3972 mL | 62.7943 mL | 78.4929 mL |
5 mM | 0.6279 mL | 3.1397 mL | 6.2794 mL | 12.5589 mL | 15.6986 mL |
10 mM | 0.314 mL | 1.5699 mL | 3.1397 mL | 6.2794 mL | 7.8493 mL |
50 mM | 0.0628 mL | 0.314 mL | 0.6279 mL | 1.2559 mL | 1.5699 mL |
100 mM | 0.0314 mL | 0.157 mL | 0.314 mL | 0.6279 mL | 0.7849 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Fucosterol
Catalog No.:BCN6427
CAS No.:17605-67-3
- (±)-Sigmoidin A
Catalog No.:BCN3372
CAS No.:176046-04-1
- Valganciclovir HCl
Catalog No.:BCC4745
CAS No.:175865-59-5
- Wedelialactone A
Catalog No.:BCN6733
CAS No.:175862-40-5
- H-Dab.HBr
Catalog No.:BCC3184
CAS No.:1758-80-1
- PPAHV
Catalog No.:BCC7077
CAS No.:175796-50-6
- Lanatoside C
Catalog No.:BCN6457
CAS No.:17575-22-3
- Lanatoside B
Catalog No.:BCN6544
CAS No.:17575-21-2
- α-Conotoxin MII
Catalog No.:BCC5743
CAS No.:175735-93-0
- Tapentadol Hydrochloride
Catalog No.:BCC9159
CAS No.:175591-09-0
- Longifloroside A
Catalog No.:BCN1123
CAS No.:175556-08-8
- Voreloxin Hydrochloride
Catalog No.:BCC2045
CAS No.:175519-16-1
- H-Val-OEt.HCl
Catalog No.:BCC3141
CAS No.:17609-47-1
- Maribavir
Catalog No.:BCC5259
CAS No.:176161-24-3
- Depressine
Catalog No.:BCN7851
CAS No.:176182-06-2
- LY 354740
Catalog No.:BCC7614
CAS No.:176199-48-7
- Nervogenic acid
Catalog No.:BCN1124
CAS No.:17622-86-5
- D-Raffinose Pentahydrate
Catalog No.:BCN2567
CAS No.:17629-30-0
- Dihydropinosylvin methyl ether
Catalog No.:BCN1125
CAS No.:17635-59-5
- Fmoc-D-Thr-ol
Catalog No.:BCC2575
CAS No.:176380-53-3
- 16alpha-Hydroxydehydrotrametenolic acid
Catalog No.:BCN1523
CAS No.:176390-66-2
- 16 alpha-Hydroxytrametenolic acid
Catalog No.:BCN2917
CAS No.:176390-68-4
- Nicotiflorin
Catalog No.:BCN1126
CAS No.:17650-84-9
- 8-Hydroxyodoroside A
Catalog No.:BCN1127
CAS No.:176519-75-8
Chemical constituents from rhizomes of Cautleya spicata (Sm.) Baker (Zingiberaceae).[Pubmed:25751012]
Nat Prod Res. 2015;29(21):2030-2.
The chemical investigation of ethanolic extract from rhizomes of Cautleya spicata (Sm.) Baker (Zingiberaceae) has resulted in the isolation of eight compounds which were characterised as beta-sitosterol (1), beta-sitosterol beta-D-glucoside (2), bergapten (3), Zerumin A (4), (E)-labda-8(17),12-diene-15,16-dial (5), kaempferol (6), quercetin (7) and astragalin (8). All compounds were identified by spectroscopic and chemical methods. This paper describes the first phytochemical work on C. spicata.
Cytotoxic constituents from the rhizomes of Curcuma zedoaria.[Pubmed:25126594]
ScientificWorldJournal. 2014;2014:321943.
Curcuma zedoaria also known as Temu putih is traditionally used in food preparations and treatment of various ailments including cancer. The cytotoxic activity of hexane, dichloromethane, ethyl acetate, methanol, and the methanol-soxhlet extracts of Curcuma zedoaria rhizomes was tested on two human cancer cell lines (Ca Ski and MCF-7) and a noncancer cell line (HUVEC) using MTT assay. Investigation on the chemical components in the hexane and dichloromethane fractions gave 19 compounds, namely, labda-8(17),12 diene-15,16 dial (1), dehydrocurdione (2), curcumenone (3), comosone II (4), curcumenol (5), procurcumenol (6), germacrone (7), zerumbone epoxide (8), zederone (9), 9-isopropylidene-2,6-dimethyl-11-oxatricyclo[6.2.1.0(1,5)]undec-6-en-8-ol (10), furanodiene (11), germacrone-4,5-epoxide (12), calcaratarin A (13), isoprocurcumenol (14), germacrone-1,10-epoxide (15), Zerumin A (16), curcumanolide A (17), curcuzedoalide (18), and gweicurculactone (19). Compounds (1-19) were evaluated for their antiproliferative effect using MTT assay against four cancer cell lines (Ca Ski, MCF-7, PC-3, and HT-29). Curcumenone (3) and curcumenol (5) displayed strong antiproliferative activity (IC50 = 8.3 +/- 1.0 and 9.3 +/- 0.3 mug/mL, resp.) and were found to induce apoptotic cell death on MCF-7 cells using phase contrast and Hoechst 33342/PI double-staining assay. Thus, the present study provides basis for the ethnomedical application of Curcuma zedoaria in the treatment of breast cancer.
Phytochemical profiling of Curcuma kwangsiensis rhizome extract, and identification of labdane diterpenoids as positive GABAA receptor modulators.[Pubmed:24011802]
Phytochemistry. 2013 Dec;96:318-29.
An ethyl acetate extract of Curcuma kwangsiensis S.G. Lee & C.F. Liang (Zingiberaceae) rhizomes (100 mug/ml) enhanced the GABA-induced chloride current (IGABA) through GABAA receptors of the alpha1beta2gamma2S subtype by 79.0+/-7.0%. Potentiation of IGABA was measured using the two-microelectrode voltage-clamp technique and Xenopus laevis oocytes. HPLC-based activity profiling of the crude extract led to the identification of 11 structurally related labdane diterpenoids, including four new compounds. Structure elucidation was achieved by comprehensive analysis of on-line (LC-PDA-ESI-TOF-MS) and off-line (microprobe 1D and 2D NMR) spectroscopic data. The absolute configuration of the compounds was established by comparison of experimental and calculated ECD spectra. Labdane diterpenes represent a new class of plant secondary metabolites eliciting positive GABAA receptor modulation. The highest efficiency was observed for Zerumin A (maximum potentiation of IGABA by 309.4+/-35.6%, and EC50 of 24.9+/-8.8 muM).
Sesquiterpenes from the rhizomes of Curcuma heyneana.[Pubmed:23387824]
J Nat Prod. 2013 Feb 22;76(2):223-9.
Four new germacranes [heyneanones A-D (1-4)], three new guaianes [4,10-epizedoarondiol (5), 15-hydroxyprocurcumenol (6), 12-hydroxycurcumenol (7)], and two new spirolactones [curcumanolides C (8) and D (9)] were isolated from the rhizomes of Curcuma heyneana together with 13 known sesquiterpenes and two known labdane-type diterpenes. Among the isolated compounds, heyneanone A (1), heyneanone C (3), 4,10-epizedoarondiol (5), procurcumenol (16), aerugidiol (17), Zerumin A (23), and (E)-15,16-bisnorlabda-8(17),11-dien-13-one (24) inhibited protein tyrosine phosphatase 1B (PTP1B) with IC(50) values of 42.5, 35.2, 35.1, 45.6, 35.7, 10.4, and 14.7 muM, respectively.
Anti-angiogenic effects and mechanisms of zerumin A from Alpinia caerulea.[Pubmed:26434281]
Food Chem. 2012 May 1;132(1):201-8.
Alpinia caerulea (R.Br.) Bentham, a perennial herb growing in tropical and subtropical Australia, is used as a flavouring spice and a ginger substitute. Its fruit has been used as indigenous food among the aboriginal Australians; 95% ethanol extracts of the dried fruits, leaves, rhizomes and roots of this plant were investigated in a zebrafish model by quantitative endogenous alkaline phosphatase assay. Only the fruit extract showed potential anti-angiogenic effect, inhibiting vessel formation by 25% at 20mug/ml. Two diterpenoids were isolated and identified as Zerumin A and (E)-8(17),12-labdadiene-15,16-dial. Zerumin A, which had mainly accumulated in the fruits and bearing a carboxylic group, could dose-dependently inhibit vessel formation, in both wild-type and Tg(fli1a:EGFP)y1 zebrafish embryos. The semi-quantitative reverse transcription polymerase chain reaction assay on wild type zebrafish embryos suggested that Zerumin A affected multiple molecular targets related to angiogenesis. Further investigation, by human umbilical vein endothelial cell assays, revealed that Zerumin A specifically inhibited the proliferation and migration steps, to prevent angiogenesis progress.
Phytochemical and cytotoxic investigations of Curcuma mangga rhizomes.[Pubmed:21629182]
Molecules. 2011 May 31;16(6):4539-48.
Investigations on the cytotoxic effects of the crude methanol and fractionated extracts (hexane, ethyl acetate) C. mangga against six human cancer cell lines, namely the hormone-dependent breast cell line (MCF-7), nasopharyngeal epidermoid cell line (KB), lung cell line (A549), cervical cell line (Ca Ski), colon cell lines (HCT 116 and HT-29), and one non-cancer human fibroblast cell line (MRC-5) were conducted using an in-vitro neutral red cytotoxicity assay. The crude methanol and fractionated extracts (hexane and ethyl acetate) displayed good cytotoxic effects against MCF-7, KB, A549, Ca Ski and HT-29 cell lines, but exerted no damage on the MRC-5 line. Chemical investigation from the hexane and ethyl acetate fractions resulted in the isolation of seven pure compounds, namely (E)-labda-8(17),12-dien-15,16-dial (1), (E)-15,16-bisnor-labda-8(17),11-dien-13-on (2), Zerumin A (3), beta-sitosterol, curcumin, demethoxycurcumin and bis-demethoxycurcumin. Compounds 1 and 3 exhibited high cytotoxic effects against all six selected cancer cell lines, while compounds 2 showed no anti-proliferative activity on the tested cell lines. Compound 1 also demonstrated strong cytotoxicity against the normal cell line MRC-5. This paper reports for the first time the cytotoxic activities of C. mangga extracts on KB, A549, Ca Ski, HT-29 and MRC-5, and the occurrence of compound 2 and 3 in C. mangga.